The United States and Germany are vying to produce an exclusive vaccine against the coronavirus which is being developed in a German laboratory, Die Welt daily reported Saturday

According to the paper, US President Donald Trump is trying to poach German scientists working on an experimental vaccine against a global health threat that has now killed some 5,500 people with a view to having an exclusive licence rolled out in the United States.

Such a vaccine would be "only for the United States," a source close to the German government told Die Welt, though Berlin would reportedly is looking to make offers of its own to biotech firm CureVac, based in the German state of Thuringia.

The company, founded in 2000, has other sites in Frankfurt and Boston.

The firm markets itself as specialising in "development of treatments against cancer, antibody-based therapies, treatment of rare illnesses and prophylactic vaccines."

The lab is currently working in tandem with the Paul-Ehrlich Institute, linked to the German ministry of health.

It specialises in vaccine research.

"The German government is very interested in having the development of vaccines and active substances against the novel coronavirus undertaken in Germany and Europe," a health ministry spokesman told Die Welt, adding that the government was in "intensive" talks with CureVac.

As CureVac CEO, Daniel Menichella found himself invited on March 2 to the White House to meet with Trump, his vice-president Mike Pence and representatives of pharma companies working on how to respond to the pandemic, the company revealed on its website without indicating if financial offers had been put on the table.

"We are very confident that we will be able to develop a potent vaccine candidate within a few months," CureVac quoted Menichella -- who has since given way to founder and incoming CEO Ingmar Hoerr -- as saying following his Washington visit.

Related Links
Epidemic News
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola

Tweet

Thanks for being here; We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain. With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor $5 Billed Once credit card or paypal		SpaceDaily Monthly Supporter $5 Billed Monthly paypal only

Last of Apple's 42 stores in China reopen
Beijing (AFP) March 13, 2020
The last of Apple's 42 stores in China reopened Friday, as the country slowly goes back to work following weeks of quarantine that forced the closure of businesses. The firm announced on February 1 that it would shut all its stores, corporate offices and contact centres across the mainland as the epidemic rapidly spread. More than 3,100 people have died and 81,000 infected in China but the number of cases has declined in recent weeks, suggesting strict quarantine measures have met some success i ... read more